1. Home
  2. PTIX vs SGBX Comparison

PTIX vs SGBX Comparison

Compare PTIX & SGBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • SGBX
  • Stock Information
  • Founded
  • PTIX 1994
  • SGBX 2007
  • Country
  • PTIX United States
  • SGBX United States
  • Employees
  • PTIX N/A
  • SGBX N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • SGBX RETAIL: Building Materials
  • Sector
  • PTIX Health Care
  • SGBX Consumer Discretionary
  • Exchange
  • PTIX Nasdaq
  • SGBX Nasdaq
  • Market Cap
  • PTIX 3.7M
  • SGBX 3.8M
  • IPO Year
  • PTIX 2016
  • SGBX 2017
  • Fundamental
  • Price
  • PTIX $0.44
  • SGBX $0.90
  • Analyst Decision
  • PTIX
  • SGBX
  • Analyst Count
  • PTIX 0
  • SGBX 0
  • Target Price
  • PTIX N/A
  • SGBX N/A
  • AVG Volume (30 Days)
  • PTIX 377.2K
  • SGBX 11.7M
  • Earning Date
  • PTIX 11-14-2024
  • SGBX 11-27-2024
  • Dividend Yield
  • PTIX N/A
  • SGBX N/A
  • EPS Growth
  • PTIX N/A
  • SGBX N/A
  • EPS
  • PTIX N/A
  • SGBX N/A
  • Revenue
  • PTIX N/A
  • SGBX $5,889,321.00
  • Revenue This Year
  • PTIX N/A
  • SGBX $273.79
  • Revenue Next Year
  • PTIX N/A
  • SGBX $39.31
  • P/E Ratio
  • PTIX N/A
  • SGBX N/A
  • Revenue Growth
  • PTIX N/A
  • SGBX N/A
  • 52 Week Low
  • PTIX $0.43
  • SGBX $0.38
  • 52 Week High
  • PTIX $1.87
  • SGBX $9.80
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 39.26
  • SGBX 67.63
  • Support Level
  • PTIX $0.43
  • SGBX $0.75
  • Resistance Level
  • PTIX $0.52
  • SGBX $1.92
  • Average True Range (ATR)
  • PTIX 0.05
  • SGBX 0.18
  • MACD
  • PTIX -0.01
  • SGBX 0.05
  • Stochastic Oscillator
  • PTIX 6.74
  • SGBX 30.76

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About SGBX Safe & Green Holdings Corp.

Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.

Share on Social Networks: